Repair Biotechnologies is a rejuvenation biotechnology company focused on damage repair approaches to aging. It is engaged in the development of gene therapy and recombinant protein approaches to address widespread and harmful age-related conditions.
Type | Private | |
Founded | 2018 | |
HQ | Syracuse, NY, US | Map |
Website | repairbiotechnologies.com |
Employees (est.) (Jan 2021) | 5 | |
Cybersecurity rating | A | More |
Founding Date | 2018 |
Repair Biotechnologies total Funding | $2.2 m |
Repair Biotechnologies latest funding size | $2.15 m |
Time since last funding | 2 years ago |
Repair Biotechnologies investors | Jim Mellon, Thynk Capital, Emerging Longevity Ventures, SENS Foundation |
When was Repair Biotechnologies founded?
Repair Biotechnologies was founded in 2018.
Who are Repair Biotechnologies key executives?
Repair Biotechnologies's key executives are Bill Cherman, Reason and Mourad Toporsian.
How many employees does Repair Biotechnologies have?
Repair Biotechnologies has 5 employees.
Who are Repair Biotechnologies competitors?
Competitors of Repair Biotechnologies include StemCyte, Genenta Science and Freeline.
Where is Repair Biotechnologies headquarters?
Repair Biotechnologies headquarters is located at Central New York Biotech Accelerator, 841 E Fayette St, Syracuse.
Where are Repair Biotechnologies offices?
Repair Biotechnologies has an office in Syracuse.
How many offices does Repair Biotechnologies have?
Repair Biotechnologies has 1 office.
Receive alerts for 300+ data fields across thousands of companies